Literature DB >> 517185

Cerebral tumours induced by ENU; changes of adenylate cyclase activity in the tumour latency time.

G Racagni, M T Giordana, S Pezzotta, F Bruno, P Paoletti, D Schiffer.   

Abstract

Tumours of the nervous system have been induced by transplacental ENU. Until the fourth month of life the tumoural lesions appear as mixed glial proliferations or oligodendroglial foci. From the fourth month on they develop as glial micro- and macrotumours or as isomorphic and polymorphic oligodendrogliomas. The adenylate cyclase activity studied during these two distinct phases of tumour development was markedly reduced in brain tumours, independent of their cellular origin, compared with the level in the normal brain. On the other hand, the activity of the enzyme responsible for the synthesis of cyclic AMP is significantly increased during the first period of tumour development when early neoplastic proliferations are present.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 517185     DOI: 10.1007/bf01813546

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  Hepatic adenyl cyclase: alterations in hormone response during treatment with a chemical carcinogen.

Authors:  T Christoffersen; J Morland; J B Osnes; K Elgjo
Journal:  Biochim Biophys Acta       Date:  1972-09-15

2.  Regulation of adenosine 3',5'-cyclic monophosphate metabolism in cultured neuroblastoma cells.

Authors:  A G Gilman; M Nirenberg
Journal:  Nature       Date:  1971-12-10       Impact factor: 49.962

3.  Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats.

Authors:  A Koestner; J A Swenberg; W Wechsler
Journal:  Am J Pathol       Date:  1971-04       Impact factor: 4.307

4.  Experimental brain tumours induced in rats by nitrosourea derivatives. II. Morphological aspects of nitrosoethylurea tumours obtained by transplacental induction.

Authors:  E Grossi-Paoletti; P Paoletti; D Schiffer; A Fabiani
Journal:  J Neurol Sci       Date:  1970-12       Impact factor: 3.181

5.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

6.  Inhibition of cell growth in vitro by adenosine 3',5'-monophosphate.

Authors:  W L Ryan; M L Heidrick
Journal:  Science       Date:  1968-12-27       Impact factor: 47.728

7.  Chemotherapeutic effects of some alkylating derivatives of nitrosourea on the development of tumors transplacentally induced in rats by ENU.

Authors:  D Schiffer; M T Giordana; S Pezzotta; P Paoletti
Journal:  Acta Neuropathol       Date:  1976-01-31       Impact factor: 17.088

8.  Cyclic AMP and adenyl cyclase in brain tumors.

Authors:  M A Furman; K Shulman
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

9.  Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine.

Authors:  R W Butcher; R J Ho; H C Meng; E W Sutherland
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

10.  Morphological transformation of Chinese hamster cells by dibutyryl adenosine cyclic 3':5'-monophosphate and testosterone.

Authors:  A W Hsie; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

View more
  2 in total

1.  Cyclic nucleotides in experimental and human brain tumors.

Authors:  G Racagni; S Pezzotta; M T Giordana; E Iuliano; I Mocchetti; G Spanu; G Sangiovanni; P Paoletti
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

2.  Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period.

Authors:  D Schiffer; M T Giordana; A Mauro; G Racagni; F Bruno; S Pezzotta; P Paoletti
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.